Exploratory study on determinant of pharmacokinetics of monoclonal antibodies in patients with advanced gastric cancer - Trial UMIN000048208
Access comprehensive clinical trial information for UMIN000048208 through Pure Global AI's free database. This phase not specified trial is sponsored by Keio University and is currently Completed. The study focuses on Gastric cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000048208
Completed
Trial Details
University Hospital Medical Information Network • UMIN000048208
Exploratory study on determinant of pharmacokinetics of monoclonal antibodies in patients with advanced gastric cancer
Study Focus
Observational
Sponsor & Location
Keio University
Japan
Timeline & Enrollment
N/A
Mar 01, 2017
N/A
ICD-10 Classifications
Gastric ulcer
Malignant neoplasm of stomach
Malignant neoplasm: Body of stomach
Carcinoma in situ: Stomach
Malignant neoplasm: Stomach, unspecified
Data Source
University Hospital Medical Information Network
UMIN000048208
Non-Device Trial